Krystyna Ossowska

Professor

Maj Institute of Pharmacology Polish Academy of Sciences

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Krystyna Ossowska is a faculty member at the Institute of Pharmacology, Polish Academy of Sciences in Poland. Her research primarily focuses on neuropharmacology, particularly the mechanisms involved in neurotoxicity, Parkinson's disease, and the therapeutic potentials of adenosine receptor modulation. Recent publications include investigations into the effects of adenosine A2A receptor blockade on motor functions, as well as the pharmacological properties of novel compounds in the context of neurodegenerative disorders.

Articles (7)

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Jadwiga Wardas

Professor

Maj Institute of Pharmacology Polish Academy of Sciences

POLAND

View details

Jolanta Konieczny

Institute of Pharmacology

POLAND

View details

Katarzyna Kuter

head of department

Maj Institute of Pharmacology Polish Academy of Sciences

POLAND

View details

Tomasz Lenda

Maj Institute of Pharmacology Polish Academy of Sciences

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Krystyna Ossowska

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system

Blockade of adenosine A2A receptors inhibits Tremulous Jaw Movements as well as expression of zif-268 and GAD65 mRNAs in brain motor structures

Antiparkinsonian-like effects of CPL500036, a novel selective inhibitor of phosphodiesterase 10A, in the unilateral rat model of Parkinson's disease

Inhibition of Excessive Glutamatergic Transmission in the Ventral Thalamic Nuclei by a Selective Adenosine A1 Receptor Agonist, 5'-Chloro-5'-Deoxy-(±)-ENBA Underlies its Tremorolytic Effect in the Harmaline-Induced Model of Essential Tremor.

Pramipexole Reduces zif-268 mRNA Expression in Brain Structures involved in the Generation of Harmaline-Induced Tremor

Potential antipsychotic action of the selective agonist of adenosine A1 receptors, 5′-Cl-5′-deoxy-ENBA, in amphetamine and MK-801 rat models

Zona incerta as a therapeutic target in Parkinson’s disease

Collaborators (4)

Jadwiga Wardas

Jolanta Konieczny

Katarzyna Kuter

Tomasz Lenda

Make your next move.